SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

$WAGMI.X is trending as the community rallies around its new branding and "WAGMI" (We're All Gonna Make It) culture, positioning it as more than just a meme. The token, built on the Solana blockchain, has a dedicated community, and many believe it is set to take off amid the current meme coin season. The community emphasizes its focus on longevity and positivity.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as community members rally around the crypto's culture-focused approach, emphasizing positivity and shared values within the cannabis community. Discussions highlight the coin's identity as a movement, not just a meme, with community members creating content and sharing links. The community is actively engaging and promoting the coin's presence in the Web3 space.

What makes MOG an absolute game-changer is our relentless dedication to memes and viral brilliance! We don't settle for mediocrity; we plunge into the realm of sheer awesomeness! Our community is a powerhouse of meme warriors, unleashing an unstoppable onslaught of viral memes that'll leave you in awe and stitches!  We're not here to play games; we're here to dominate! MOG is all about pushing the boundaries, smashing through barriers, and leaving our competitors eating our dust! Our passion for humor burns like an inferno, and we won't rest until the entire internet bows down to our meme supremacy!  And our community? It's a brotherhood, an unyielding powerhouse of support and camaraderie! When you're part of MOG, you're part of an unstoppable force, a family forged by the fire of meme revolution!  So, if you're ready to be part of the most intense, mind-bending memecoin movement ever conceived, then buckle up, strap in, and brace yourself! MOG is here to claim the throne, and we're taking no prisoners! Get ready to witness meme history in the making!

 MOG Coin

MOG Coin is trending as the community anticipates potential gains, drawing comparisons to coins like Shiba Inu and Doge. Discussions revolve around the possibility of wiping out zeros from its price and achieving substantial returns, with some looking at positive price predictions. News about Trump signing deals and other coins trending is also fueling excitement around altcoins.

The 401jk (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and also the 401k. The 401k total holdings are valued at around $12 trillion USD and it is the most popular retirement savings plan in the US. As time passes forevermore true retirement, or as we like to call it real freedom will only become much harder and harder for people to attain.  Through meme fueled laser focus and cyperphunk ideology the 401jK meme retirement fund token and community aim to point out the absurdities of how rigged our current system is, and how only insiders and those with power are starting the benefit from the increased centralization of cryptocurrency.........while also aiming to flip the $12 trillion USD 401k system to achieve freedom before our backs and knees are breaking.

401jK

401JK.X is trending as a meme token on the Solana network, with the community rallying around its satirical take on traditional retirement plans. The coin's narrative of "early retirement" and strong community engagement are key drivers, with many expressing bullish sentiment and anticipating further gains. Discussions highlight the token's potential as an alternative to conventional 401(k)s, attracting attention within the crypto meme coin landscape.

"What's Updog?" is a Community Led token.

UpDog

UpDog ($UPDOG.X) is trending within the crypto community, with conversations centered around its potential for exponential growth on the Solana network and recent accumulation by top holders. Community members are drawn to its rock-solid fundamentals, locked liquidity, and status as the only UpDog on the Jupiter Strict List, fueling excitement for a potential surge. The project's playful meme-inspired branding, combined with its Solana-based infrastructure, is attracting attention as a unique opportunity in the crypto space.

Trump For President

The TRUMP.X cryptocurrency is trending amid ongoing political discussions and community speculation about its future. Some traders are expressing concerns about its performance and potential for further decline, while others are focused on its potential upside due to its association with Donald Trump. Community members are actively debating political issues and the token's prospects.

Pump.fun

PUMP.X is trending as the community discusses its potential as a platform, rather than just another meme coin, emphasizing its ecosystem and the revenue distribution model. Traders are actively watching for a breakout, with some pointing to the increasing number of watchers and potential for substantial gains. The conversation also includes speculation around new streaming opportunities and potential listings.

DePhyneAI is a decentralized physical AI infrastructure enabling autonomous devices such as drones, robots, and edge sensors to perform intelligent tasks while earning rewards in the native token, $DPHY. The network is permissionless, community-owned, and designed to bring scalable, secure AI computation to the edge of the real world.  1. Introduction Artificial Intelligence has historically been confined to centralized cloud platforms. However, as physical devices grow more capable, the future lies in enabling intelligence directly on the edge - embedded in the real world. DePhyneAI empowers a decentralized network of autonomous agents to train, infer, and collaborate - creating a self-sustaining AI ecosystem governed by a native token economy.  What is DePhyneAI? DePhyneAI is an open, decentralized network where physical devices act as nodes. Each device contributes compute, data, or services and is rewarded in $DPHY tokens. The network supports:  Federated learning and on-device AI inference Secure blockchain-based coordination Real-time decision-making in physical environments Use Cases DePhyneAI supports diverse real-world applications:  Logistics: AI-enabled autonomous drone deliveries Agriculture: Monitoring soil, crop health, irrigation using robotic systems Smart Cities: Surveillance, traffic analysis, energy optimization Disaster Response: Real-time aerial monitoring and situational AI Why $DPHY Matters The $DPHY token is the lifeblood of the DePhyneAI network. It serves multiple purposes:  Rewards: Earned by node operators who run AI tasks Access: Used to access AI models, data feeds, and services Governance: Voting and proposal mechanisms Staking: Ensures quality and uptime guarantees

DePhyneAI

DePhyneAI ($DPHYAI.X) is trending as part of the AI crypto wave, with community members highlighting its potential as a microcap play. Conversations revolve around its early-stage activity and potential within the broader AI narrative. Some users are discussing liquidity and future utility.

Jupiter is a cryptocurrency exchange platform on the Solana blockchain, offering features such as token swapping, limit orders, dollar-cost averaging, and a bridge for asset transfers to Solana. It provides users with tools to find the best trading prices and includes a beta version for perpetual futures trading. Jupiter finds the best price route for your swap by aggregating all the major liquidity sources on Solana.

Jupiter

Jupiter ($JUP.X) is trending amid community excitement surrounding its ecosystem growth and potential for meme coin dominance. Discussions highlight UpDog's ($UPDOG.X) surge on the platform, with community members focusing on its growing holder base and potential for exponential growth similar to $SHIB.X. Additionally, Jupiter Lend's milestones and the anticipation of the next $JUP airdrop are fueling interest.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to a recently announced AI server contract, driving excitement among investors. The community is actively discussing the stock's low float and potential for a short squeeze, with many expressing bullish sentiment and anticipating further upward movement. High borrow fees and zero shares available to short are adding fuel to the speculative fire.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TPST Stock Up on EMA's Orphan Drug Tag for Liver Cancer Therapy

Shares of Tempest Therapeutics (TPST) ended higher on Wednesday amid a broader market rebound on the U.S. pausing tariffs and extended gains after-hours after the company said it was exploring strategic alternatives.&nbsp;The cancer drug developer said its options included a merger, acquisition, partnership, or licensing deal to advance its pipeline and maximize shareholder value.&nbsp;The company has retained MTS Health Partners to assist with the process.CEO Stephen Brady emphasized the company's strong data and regulatory momentum, pointing to Phase 2 results for amezalpat showing a six-month survival benefit in advanced liver cancer and FDA clearance for a pivotal Phase 3 study.&nbsp;However, Brady said capital markets "have been unavailable to support the next stage of advancement."On Stocktwits, sentiment for Tempest surged into the 'extremely bullish' zone from 'neutral' a day ago, accompanied by message volume soaring over 135% in the 24 hours to late Wednesday.<figure class="image"><img style="aspect-ratio:1318/316;" src="https://news.stocktwits-cdn.com/TPST_sentiment_and_message_volume_April_9_png_4939200400.webp" alt="TPST sentiment and message volume April 9.png" width="1318" height="316"><figcaption>TPST sentiment and message volume April 9. | source: Stocktwits</figcaption></figure>One user said the CEO was "soliciting bidders" through this move following the recent 1-for-13 reverse stock split."Poison pill is still at $25. Now, anyone who wants more than a 10 percent ownership stake can buy whatever they want at $25 or more. Well played, Mr. Brady!" they wrote.<stembedurl>https://stocktwits.com/xyz1232/message/611152790</stembedurl>Another pinned hopes on "well-known" MTS Partners fetching a good merger deal for Tempest. "Even If TPST gets a below-average deal at $360 million, we're still looking at $100 per share."<stembedurl>https://stocktwits.com/GreylockSec/message/611168891</stembedurl>Amezalpat, Tempest's lead candidate, has received both Orphan Drug and Fast Track designations from the FDA.&nbsp;TPST-1495, a dual EP2/EP4 antagonist, is also advancing toward a Phase 2 trial in familial adenomatous polyposis (FAP) with NCI support.<a href="https://stocktwits.com/symbol/TPST">Tempest Therapeutics stock</a> has lost over 34% this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stockbroker analyzing financial stock market with reflection on eyeglasses. Photo via Westend61 on Getty Images

Tempest Therapeutics Retail Chatter Explodes As Cancer Drug Developer Mulls Possible Merger

CEO Stephen Brady emphasized the company's strong data and regulatory momentum, pointing to Phase 2 results for amezalpat in advanced liver cancer and FDA clearance for a pivotal Phase 3 study. 

Equity

Why Is Small-Cap Tempest Therapeutics Stock Trading Higher On Thursday?

Tempest Therapeutics receives FDA feedback on the Phase 3 trial design for amezalpat (TPST-1120) in combination with Tecentriq and Avastin to treat first-line hepatocellular carcinoma. Study to begin...

What's Going On With Cancer-Focused Tempest Therapeutics Stock On Thursday?

Tempest Therapeutics shares drop 13% to $2.48 on Thursday despite promising new data from its Phase 1b/2 study. The study shows a six-month survival improvement in hepatocellular carcinoma patients...

Glancy Prongay & Murray LLP Announces Investigation of Tempest Therapeutics, Inc. (TPST)

Glancy Prongay & Murray LLP (GPM) announces its investigation of Tempest Therapeutics, Inc. (Nasdaq: TPST) concerning the Company and its directors and officers possible violations of state laws. If...

Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications

TPST-1120, a first-in-class, oral, selective PPAR antagonist, demonstrates clinical activity in PD-1 inhibitor refractory and immune compromised cancersBased on subsequent positive randomized data...

Tempest Therapeutics, Inc. (NASDAQ:TPST) Expected to Post Q1 2024 Earnings of ($0.36) Per Share

Tempest Therapeutics, Inc. (NASDAQ:TPST  Free Report)  HC Wainwright issued their Q1 2024 earnings estimates for Tempest Therapeutics in a report released on Wednesday, March 20th...

Tempest Therapeutics (NASDAQ:TPST) Stock Rating Reaffirmed by HC Wainwright

Tempest Therapeutics (NASDAQ:TPST  Get Free Report)s stock had its buy rating restated by HC Wainwright in a research report issued to clients and investors on Wednesday...

Tempest Therapeutics (NASDAQ:TPST) Stock Rating Reaffirmed by William Blair

Tempest Therapeutics (NASDAQ:TPST  Get Free Report)s stock had its outperform rating restated by investment analysts at William Blair in a note issued to investors on...

Tempest Reports Year End 2023 Financial Results and Provides Business Update

Announced positive randomized first-line HCC data showing superiority of TPST-1120 combination therapy across multiple study endpoints compared to standard of careReported new biomarker data in two...

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest Therapeutics was founded in 2011 and is headquartered in Brisbane, CA.

Tempest Therapeutics Inc

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

Current Price	$10.23
Prev Close	$10.01
Open	$10.15
Dividend Yield	0.00%
50-Day Moving Average	$8.77
Beta	1.86
Avg. Volume	82,424.81
PE Ratio	-0.69

52-Week High	$20.67
52-Week Low	$5.35
Market Capitalization	$44.98M
EPS (Annual)	-$19.50
Price to Book	4.60
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

TPST
Tempest Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TPST News

TPST Tempest Therapeutics Inc